Sign Out
GAMUNEX-C is an immune globulin injection (human) 10% liquid that is indicated for the treatment of: Primary Humoral Immunodeficiency (PI): GAMUNEX-C is indicated as replacement therapy of primary humoral immunodeficiency. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Idiopathic Thrombocytopenic Purpura (ITP): GAMUNEX-C is indicated for the treatment of patients with Idiopathic Thrombocytopenic Purpura to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): GAMUNEX-C is indicated for the treatment of CIDP to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse.
